Latest biopsy approach for suspected metastases in patients with breast cancer (Q38154494)

29 August 2017

Latest biopsy approach for suspected metastases in patients with breast cancer (English)

1 reference

29 August 2017

5

Gabriel N Hortobagyi

1 reference

29 August 2017

Naoki Niikura

1

1 reference

29 August 2017

Bruno C Odisio

2

1 reference

29 August 2017

Yutaka Tokuda

3

1 reference

29 August 2017

Fraser W Symmans

4

1 reference

29 August 2017

Naoto T Ueno

6

1 reference

29 August 2017

language of work or name

English

0 references

publication date

22 October 2013

1 reference

Nature Reviews Clinical Oncology

29 August 2017

1 reference

29 August 2017

10

1 reference

29 August 2017

12

1 reference

29 August 2017

711-719

1 reference

Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

29 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Estrogen and HER-2 receptor discordance between primary breast cancer and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Advances in medical imaging for cancer diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Primer on imaging technologies for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Positron Emission Tomography (PET) and breast cancer in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

New horizons in oncologic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

State-of-the-art adrenal imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Image-guided percutaneous needle biopsy in cancer diagnosis and staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

New techniques in image-guided percutaneous biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Percutaneous abdominal biopsy: cost-identification analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Centennial dissertation. Percutaneous imaging-guided core breast biopsy: state of the art at the millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Cost-effectiveness of ultrasound-guided liver biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Ultrasound guided percutaneous fine needle aspiration biopsy/automated needle core biopsy of abdominal lesions: effect on management and cost effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

MR-guided liver biopsy within a short, wide-bore 1.5 Tesla MR system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

MRI-guided abdominal biopsy in a 0.23-T open-configuration MRI system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Ascitic fluid analysis in malignancy-related ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Acquisition of metastatic tissue from patients with bone metastases from breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Technical pitfalls potentially affecting diagnoses in immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Combining fine-needle aspiration and core biopsy under CT fluoroscopy guidance: a better way to treat patients with lung nodules?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Fine-needle aspiration biopsy versus core-needle biopsy in diagnosing lung cancer: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Breast cancer seeding associated with core needle biopsies: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Immunohistochemical detection of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast carcinomas: comparison on cell block, needle-core, and tissue block preparations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Dynamic and modern: bringing the ethics of phase I trials up to date.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

BSCC Code of Practice--fine needle aspiration cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Value of having a cytopathologist present during percutaneous fine-needle aspiration biopsy of lung: report of 55 cancer patients and metaanalysis of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

CT and sonographically guided needle biopsy: current techniques and new innovations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Percutaneous transthoracic CT guided biopsies of lung lesions; fine needle aspiration biopsy versus core biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Evaluation of new monoclonal antibodies in detection of estrogen receptor, progesterone receptor, and Her2 protein expression in breast carcinoma cell block sections using conventional microscopy and quantitative image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

HER-2 testing in breast cancer using parallel tissue-based methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Delay to formalin fixation effect on breast biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Should a biopsy be recommended to confirm metastatic disease in women with breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Differences in the receptor status between primary and recurrent breast cancer--the frequency of and the reasons for discordance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Hormonal receptor, human epidermal growth factor receptor-2, and Ki67 discordance between primary breast cancer and paired metastases: clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

A comparison of HER2/neu gene amplification and its protein overexpression between primary breast cancer and metastatic lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

HER-2/neu expression in primary and metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Impact of metastatic estrogen receptor and progesterone receptor status on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Clinical efforts to combine endocrine agents with targeted therapies against epidermal growth factor receptor/human epidermal growth factor receptor 2 and mammalian target of rapamycin in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

The need to examine metastatic tissue at the time of progression of breast cancer: is re-biopsy a necessity or a luxury?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Estrogen receptor (ER) mRNA and ER-related gene expression in breast cancers that are 1% to 10% ER-positive by immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Discordant human epidermal growth factor receptor 2 and hormone receptor status in primary and metastatic breast cancer and response to trastuzumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Stability of estrogen receptor status in breast carcinoma: a comparison between primary and metastatic tumors with regard to disease course and intervening systemic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Hormone receptor and c-ERBB2 status in distant metastatic and locally recurrent breast cancer. Pathologic correlations and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Prognostic value of c-erbB2 expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Loss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Sequence analysis of mutations and translocations across breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Building a personalized medicine infrastructure at a major cancer center

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Steroid receptor ligands for breast cancer targeting: an insight into their potential role as PET imaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

The progress and promise of molecular imaging probes in oncologic drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Circulating tumour cells and cell-free DNA as tools for managing breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Improved detection of small lung cancers with dual-energy subtraction chest radiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Quality improvement guidelines for percutaneous needle biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Sonography: the undiscovered jewel of interventional radiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Coaxial percutaneous biopsy technique with automated biopsy devices: value in improving accuracy and negative predictive value

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Influence of fixation and decalcification on the immunohistochemical staining of cell-specific markers in paraffin-embedded human bone biopsies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Sonographically guided percutaneous biopsy of small (3 cm or less) masses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Blinded comparison of biopsy needles and automated devices in vitro: 2. Biopsy of medical renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Expression of estrogen and progesterone receptors in cytologic specimens using various fixatives

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

HER2 status in a population-derived breast cancer cohort: discordances during tumor progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Change of HER-2/neu status in a subset of distant metastases from breast carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

c-erbB-2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Docetaxel, cisplatin, and trastuzumab as primary systemic therapy for human epidermal growth factor receptor 2-positive locally advanced breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Whole-genome analysis informs breast cancer response to aromatase inhibition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.182

Amplification of HER-2/neu and topoisomerase IIalpha in primary and metastatic breast cancer.

31 March 2020

1 reference

12 December 2020

Assessment of Her-2/neu overexpression in primary breast cancers and their metastatic lesions: an immunohistochemical study

1 reference

12 December 2020

HER-2/neu detection in fine-needle aspirates of breast cancer: fluorescence in situ hybridization and immunocytochemical analysis

1 reference

12 December 2020

The positive peritoneal effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation

1 reference

12 December 2020

Image-directed percutaneous biopsy with large-core needles. Comparison of cytologic and histologic findings

1 reference

12 December 2020

Comparison of estrogen receptors, progesterone receptors and HER-2/neu expression between primary and metastatic breast carcinoma.

1 reference

12 December 2020

Tumour dormancy and clinical implications in breast cancer.

1 reference

12 December 2020

Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma

1 reference

12 December 2020

Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.

1 reference

12 December 2020

HER-2/neu status of primary breast cancer and corresponding metastatic sites in patients with advanced breast cancer treated with trastuzumab-based therapy

1 reference

12 December 2020

Primary extraosseous Ewing sarcoma of the lung in children

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.3332/ECANCER.2013.312

Identifiers

DOI

10.1038/NRCLINONC.2013.182

1 reference

29 August 2017

1 reference